On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

In the frantic rush to find drug combinations that maximize immune checkpoint inhibitor effectiveness, Bristol-Myers Squibb (BMS) just put a lot of chips on the table. On Wednesday, the company cut a ...

Bristol-Myers Squibb's has become the first company to bring a cardiac myosin inhibitor through to FDA approval, claiming a green light from the US regulator for mavacamten as a therapy for ...

EV companies take cheap solutions from laptops and integrate them into complicated battery management systems, allege Lars Reger Reger attributed the use of such bandaid solutions to the razor-thin ...